Skip to main content
Loading

GenEndeavor

Monday, February 26, 2024
Plymouth
Diagnostics
GenEndeavor is a molecular diagnostics technology company on a mission to prevent genetic and infectious diseases by quickly and accurately detecting pathological biomarkers in early stages.
Speakers
Ricardo Mancebo, CEO - Genendeavor

State

CA

Country

United States

Website

http://www.genendeavor.com

CEO/Top Company Official

Ricardo Mancebo

Lead Product in Development

Point of care, non-invasive early ovarian cancer monitoring test for existing patients and asymptomatic high-risk women

Development Phase of Primary Product

Pre-Clinical

Number Of Unlicensed Products

1
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP